NCT05874583View on ClinicalTrials.gov

Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid

NACompletedINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

December 1, 2021

Primary Completion Date

September 30, 2022

Study Completion Date

December 31, 2022

Conditions
Tranexamic AcidArthroplasty, Replacement, KneeBlood TransfusionArthroplasty, Replacement, Hip
Interventions
DRUG

Combined route administration of Tranexamic acid

tranexamic acid in topical route administration

DRUG

Intravenous route Tranexamic acid injection

Intra venous route administration

Trial Locations (1)

2046

Mongi Slim University Hospital, La Marsa

All Listed Sponsors
lead

Mongi Slim Hospital

OTHER

NCT05874583 - Prevention of Bleeding in Total Joint Replacement: Combined Route Administration of Tranexamic Acid | Biotech Hunter | Biotech Hunter